Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden · Delayed Price · Currency is SEK 1.130
+0.278 (32.63%)
Mar 4, 2026, 5:29 PM CET
Prostatype Genomics AB Market Cap
Prostatype Genomics AB has a market cap or net worth of 66.88 million as of March 4, 2026. Its market cap has increased by 67.66% in one year.
Market Cap
66.88M
Enterprise Value
57.82M
Revenue
594.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
1.13
Market Cap Chart
Since November 3, 2020, Prostatype Genomics AB's market cap has decreased from 92.30M to 66.88M, a decrease of -27.54%. That is a compound annual growth rate of -5.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 4, 2026 | 66.88M | 276.67% |
| Dec 30, 2025 | 17.76M | -76.14% |
| Dec 30, 2024 | 74.42M | 555.78% |
| Dec 29, 2023 | 11.35M | -76.58% |
| Dec 30, 2022 | 48.46M | -64.07% |
| Dec 30, 2021 | 134.89M | -28.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 136.67B |
| Getinge AB | 55.26B |
| Sectra AB | 37.34B |
| Medicover AB | 32.84B |
| Alzinova AB | 64.05M |
| Enorama Pharma AB | 56.84M |
| ScandiDos AB | 55.98M |
| Pila Pharma AB | 54.82M |